SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-22-000649
Filing Date
2022-04-28
Accepted
2022-04-27 21:23:01
Documents
12
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K medicure6k.htm 6-K 13496
2 2021 ANNUAL FINANCIAL STATEMENTS ex991.htm EX-99.1 647557
3 2021 MANAGEMENT'S DISCUSSION AND ANALYSIS ex992.htm EX-99.2 298415
4 CEO CERTIFICATION ex993.htm EX-99.3 5694
5 CFO CERTIFICATION ex994.htm EX-99.4 5711
6 GRAPHIC image_001.jpg GRAPHIC 1927
7 GRAPHIC medicureheader.jpg GRAPHIC 3015
8 GRAPHIC medicurelogo.jpg GRAPHIC 4526
9 GRAPHIC ey_sig.jpg GRAPHIC 7541
10 GRAPHIC pwc_sig.jpg GRAPHIC 8527
11 GRAPHIC pwc_logo.jpg GRAPHIC 5019
12 GRAPHIC ey_footer.jpg GRAPHIC 8383
  Complete submission text file 0001279569-22-000649.txt   1026457
Mailing Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6
Business Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6 204-487-7412
MEDICURE INC (Filer) CIK: 0001133519 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31995 | Film No.: 22861847
SIC: 2834 Pharmaceutical Preparations